| Trista Louise Grossnickle, PMHNP | |
|
400 W Glenn Miller Dr, Clarinda, IA 51632-2963 | |
| (712) 542-8354 | |
| (712) 517-1192 |
| Full Name | Trista Louise Grossnickle |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 400 W Glenn Miller Dr, Clarinda, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346993763 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | G167240 (Iowa) | Primary |
| Entity Name | Clarinda Regional Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629196241 PECOS PAC ID: 4587573993 Enrollment ID: O20031205000207 |
News Archive
Probiodrug AG announced today the transfer of its experimental cyclin-dependent kinase 9 inhibitor program to AstraZeneca. The transaction includes the sale to AstraZeneca of a lead molecule and back-up compounds with the associated intellectual property. CDK9, which has been implicated in the transcriptional regulation of genes involved in proliferation and inflammation, is a promising target for the treatment of both cancer and inflammatory diseases.
Bruker Corporation today announces the signing of an agreement to acquire the Scanning Probe Microscopy (SPM) and Optical Industrial Metrology (OIM) instruments business from Veeco Instruments, Inc. for $229 million in cash. The transaction has been approved by the Boards of Directors of both companies and is expected to close during the fourth quarter of 2010, pending regulatory review and subject to customary closing conditions.
Medications or biologic agents that target T-cells, white blood cells involved in the body's immune system, appear to offer significant benefit to patients suffering from psoriatic arthritis (PsA), a type of arthritis that affects up to 48 percent of patients with the skin disease psoriasis, according to a new review article in the Journal of the American Academy of Orthopaedic Surgeons.
Using electrodes to stimulate areas deep within the brain may have therapeutic potential for patients with obsessive compulsive disorder that is refractory to treatment, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
When President Obama recently recounted the story of a woman he said was denied coverage for failure to own up to a skin condition when she enrolled in a plan, he was incorrect, The Associated Press reports.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Trista Louise Grossnickle, PMHNP 400 W Glenn Miller Dr, Clarinda, IA 51632-2963 Ph: (712) 542-8354 | Trista Louise Grossnickle, PMHNP 400 W Glenn Miller Dr, Clarinda, IA 51632-2963 Ph: (712) 542-8354 |
News Archive
Probiodrug AG announced today the transfer of its experimental cyclin-dependent kinase 9 inhibitor program to AstraZeneca. The transaction includes the sale to AstraZeneca of a lead molecule and back-up compounds with the associated intellectual property. CDK9, which has been implicated in the transcriptional regulation of genes involved in proliferation and inflammation, is a promising target for the treatment of both cancer and inflammatory diseases.
Bruker Corporation today announces the signing of an agreement to acquire the Scanning Probe Microscopy (SPM) and Optical Industrial Metrology (OIM) instruments business from Veeco Instruments, Inc. for $229 million in cash. The transaction has been approved by the Boards of Directors of both companies and is expected to close during the fourth quarter of 2010, pending regulatory review and subject to customary closing conditions.
Medications or biologic agents that target T-cells, white blood cells involved in the body's immune system, appear to offer significant benefit to patients suffering from psoriatic arthritis (PsA), a type of arthritis that affects up to 48 percent of patients with the skin disease psoriasis, according to a new review article in the Journal of the American Academy of Orthopaedic Surgeons.
Using electrodes to stimulate areas deep within the brain may have therapeutic potential for patients with obsessive compulsive disorder that is refractory to treatment, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
When President Obama recently recounted the story of a woman he said was denied coverage for failure to own up to a skin condition when she enrolled in a plan, he was incorrect, The Associated Press reports.
› Verified 6 days ago
Renee Nauman, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 220 Essie Davison Dr, Clarinda, IA 51632 Phone: 712-542-2176 | |
Katie Burns, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 220 Essie Davison Dr, Clarinda, IA 51632 Phone: 712-542-8330 Fax: 712-542-8397 | |
Cris L Morrow, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 220 Essie Davison Dr, Clarinda, IA 51632 Phone: 712-542-2176 Fax: 712-542-8201 | |
Mandy Lynn Woods, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 220 Essie Davison Dr, Clarinda, IA 51632 Phone: 712-542-8330 | |
Kirsten Noel Hamilton, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 220 Essie Davison Dr, Clarinda, IA 51632 Phone: 712-542-2176 | |
Talisha I Furst, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 220 Essie Davison Dr, Clarinda, IA 51632 Phone: 712-542-2176 Fax: 712-542-8311 | |
Lauren Rae Davison, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 220 Essie Davison Dr, Clarinda, IA 51632 Phone: 712-542-2176 |